Ambit Biosciences Corporation

Ambit Biosciences Corporation is a publicly traded company as of May 2013.
Below is PrivCo's archived report for Ambit Biosciences Corporation

What's included with your PrivCo Report Purchase:

Next Actions on Ambit Biosciences Corporation:

Business Summary

Ambit Biosciences Corporation is a privately-held, venture capital backed biotechnology company and was formerly known as Aventa Biosciences Corporation. Ambit Biosciences Corporation is engaged in the development of small molecule therapeutics for the treatment of cancer. Founded in 2000, Ambit Biosciences Corporation is headquartered in San Diego, California.

Overview & Corporate Organization

Basic Information

Company Tags:	PE Backed VC Backed
Year Founded:	2000
Formerly Named:	Aventa Biosciences Corporation
Fiscal Year End:	12/31
1YR Revenue Growth Rate:	View %
1YR Employee Growth Rate:	View %
City:	San Diego
State/Province:	California
Country:	United States
Phone:	View
Fax:	View
Website:	www.ambitbio.com

Industry Information

Industry Codes

PICS™:	1500199™
NAICS:	View
SIC:	View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology > Other Biotechnology

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

Ownership

PrivCo's Ownership table displays who owns Ambit Biosciences Corporation, including owner name, each type of owner (whether family, individual, private equity firm, etc.)

Owner Name	Type of Owner	% Ownership Stake
View	View	View
View	View	View
View	View	View
View	View	View
View	View	View
View	View	View
View	View	View
View	View	View
View	View
View	View
View	View
View	View
View	View
View	View
View	View

Charts, Financials, and Statistics (Table Format)

Below are Ambit Biosciences Corporation financials and other business metrics displayed in table format.
Copy & Paste Financials Into Spreadsheet or

Export All Ambit Biosciences Corporation Financials To Excel

All data before 2006 is completely free to view! To access data from 2006 onward:

Worldwide
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Washington, D.C.
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Canada
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Europe (all countries)
UK
Germany
France
Italy
Europe (excluding UK)
Asia-Pacific (all countries)
Australia
China
Hong Kong
India
South Korea
Taiwan
Japan
Asia-Pacific (excluding India)
Latin America (all countries)
Middle East & Africa (all countries)

Get Full Access To This Report	or	Upgrade to PrivCo Premium
$99 Single Company Access		Instant Full Site-Wide Access *Currently 50% Off Until May. 31!*

Income Statement	2012	2011	2010	2009	2008
Other Sales Revenue, Net - Services			View	View	View
Revenue from Contract	View	View
Other Operating Revenue			View	View	View
Revenue			View	View	View
Cost of Services - Other			View	View	View
General and Administrative Expenses	View	View	View	View	View
In - Process Research and Development			View	View	View
Research and Development Expense (Excluding In - Process)	View	View	View	View	View
Total Operating Expenses excluding costs	View	View	View	View	View
Operating Income/(Loss)	View	View	View	View	View
Interest Expense	View	View	View	View	View
Gain/(Loss) on Sale of Business	View	View
Other Nonoperating-Asset Related Income	View	View
Nonoperating Income - Other	View	View
Nonoperating Income/(Expense) - Other			View	View	View
Nonoperating Income/(Expense)	View	View	View	View	View
Income/(Loss) from Continuing Operations Before Income Taxes	View	View	View	View	View
Provision for Income Taxes	View	View	View	View	View
Minority Interest, Net of Tax Effect	View	View	View	View	View
Net Income	View	View	View	View	View
Other Preferred Stock Dividends and Adjustments	View	View	View	View	View
Net Income Applicable to Common Stockholders	View	View	View	View	View
Comprehensive Foreign Currency Exchange Gains/(Losses)	View	View
Total Comprehensive Net Income	View	View

Balance Sheet	2012	2011	2010	2009
Cash and Cash Equivalents	View	View	View	View
Short-Term Investments			View	View
Current Restricted Cash			View	View
Net Accounts Receivable Trade	View	View	View	View
Prepaid Expenses	View	View	View	View
Current Assets Held-for-Sale			View	View
Current Assets	View	View	View	View
Net Property, Plant and Equipment	View	View	View	View
Noncurrent Other Assets	View	View	View	View
Assets	View	View	View	View
Employee Related Liabilities	View	View	View	View
Other Accounts Payable and Accrued Expenses	View	View	View	View
Current Deferred/(Unearned) Revenue	View	View	View	View
Current Notes Payable	View	View	View	View
Current Liabilities Held for Sale			View	View
Current Other Liabilities	View	View
Current Liabilities	View	View	View	View
Notes Payable - Long-Term	View	View	View	View
Derivative Liabilities - Long-Term			View	View
Minority Interest	View	View	View	View
Deferred/(Unearned) Revenue - Long-Term	View	View	View	View
Noncurrent Other Liabilities	View	View	View	View
Convertible Preferred Stock Obligations	View	View	View	View
Redeemable Preferred Stock Obligations			View	View
Redeemable Convertible Preferred Stock Obligations			View	View
Common Stock - Value (Excluding Additional Paid in Capital)	View	View	View	View
Additional Paid in Capital	View	View	View	View
Retained Earnings	View	View	View	View
Other Accumulated Comprehensive Income, Net of Tax Effect	View	View	View	View
Equity - Other			View	View
Stockholders' Equity	View	View	View	View
Liabilities and Stockholders' Equity	View	View	View	View

Cash Flow Statement	2012	2011	2010	2009	2008
Operating Activities Beginning Net Income	View	View	View	View	View
Amortization			View	View	View
Depreciation and Amortization	View	View	View	View	View
Adjustment In-Process Research and Development			View	View	View
Total Adjustments to Provision for Doubtful Accounts	View	View
Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment	View	View	View	View	View
Adjustments to Gain/(Loss) on Sale of Business	View	View
Adjustment Deferred Revenue	View	View	View	View	View
Adjustment for Equity Based Compensation Expense	View	View	View	View	View
Adjustment Derivatives	View	View
Adjustments to Other Deferred Charges	View	View	View	View	View
Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease)			View	View	View
Noncash Expenses - Other	View	View	View	View	View
Change Accounts Receivable	View	View	View	View	View
Current Increase/(Decrease) in Notes Receivable - Related Parties			View	View	View
Change Assets Held for Sale			View	View	View
Change Deposit Other Assets			View	View	View
Change Prepaid Expenses Other Current Assets	View	View	View	View	View
Increase/(Decrease) in Accounts Payable and Accrued Expenses	View	View	View	View	View
Net Increase/(Decrease) in Interest Payable			View	View	View
Increase/(Decrease) in Employee Related Liabilities	View	View	View	View	View
Net Cash Flows Provided By/(Used In) Operating Activities	View	View	View	View	View
Purchase of Property, Plant and Equipment	View	View	View	View	View
Increase Decrease Restricted Funds			View	View	View
Proceeds from Divestiture of Business	View	View
Net Proceeds from Sale of Short-Term Investments			View	View	View
Net Purchase of Short-Term Investments			View	View	View
Proceeds from Sale of Property, Plant and Equipment			View	View	View
Net Cash Flows Provided By/(Used In) Investing Activities	View	View	View	View	View
Proceeds from Notes Payable	View	View	View	View	View
Repayments on Notes Payable	View	View	View	View	View
Proceeds from Issuance of Common Stock	View	View
Proceeds from Issuance of Convertible Preferred Stock	View	View	View	View	View
Proceeds from Stock Options Exercised			View	View	View
Proceeds Issuance Minority Interest			View	View	View
Increase/(Decrease) in Other Equity	View	View
Repurchase Initial Public Offering	View	View
Stock Issuance Costs			View	View	View
Net Cash Flows Provided By/(Used In) Financing Activities	View	View	View	View	View
Effect of Exchange Rate on Cash and Cash Equivalents	View	View	View	View	View
Increase/(Decrease) in Cash and Cash Equivalents	View	View	View	View	View
Cash and cash equivalents at the beginning of the year	View	View	View	View	View
Total Cash and cash equivalents at the end of the year	View	View	View	View	View
Income Taxes Paid	View	View	View	View	View
Cash Interest Expense	View	View	View	View	View
Conversion of Debt Securities			View	View	View
Stock Issued			View	View	View
Supplemental Other Net	View	View

Financial Notes:
*	Ambit Biosciences Corporation fiscal year end: 12/31

	Date	Investor	Round	Investor Type
	Dec. 2000	Unspecified Investors	Seed
Details		Total Round Seed $2,000,000
	Jun. 2001	Aisling Capital	A	Private Equity
	Jun. 2001	Forward Ventures	A	Venture Capital
	Jun. 2001	Unspecified Investors	A
Details		Total Round A $8,800,000
	Nov. 2001	Aisling Capital	B	Private Equity
	Nov. 2001	Forward Ventures	B	Venture Capital
	Nov. 2001	Baker-Tisch Investments	B	Other Investment Firm
Details		Total Round B $10,000,000
	May. 2002	Avalon Ventures	Funding	Venture Capital
	May. 2002	Forward Ventures	Funding	Venture Capital
	May. 2002	Gimv NV	Funding	Private Equity
	May. 2002	Perseus LLC	Funding	Private Equity
Details		Total Round Funding $18,800,000
	Aug. 2004	Avalon Ventures	C	Venture Capital
	Aug. 2004	F. Hoffmann-La Roche Ltd	C	Corporate
Details		Total Round C $21,000,000
	Mar. 2005	Avalon Ventures	Funding	Venture Capital
	Mar. 2005	F. Hoffmann-La Roche Ltd	Funding	Corporate
	Mar. 2005	Forward Ventures	Funding	Venture Capital
	Mar. 2005	GeneChem Management Inc.	Funding	Venture Capital
	Mar. 2005	Gimv NV	Funding	Private Equity
	Mar. 2005	Lumira Capital Corporation	Funding	Venture Capital
	Mar. 2005	GrowthWorks Capital Ltd.	Funding	Venture Capital
	Mar. 2005	Perseus LLC	Funding	Private Equity
Details		Total Round Funding $1,430,000
	May. 2005	Aisling Capital	C	Private Equity
	May. 2005	Avalon Ventures	C	Venture Capital
	May. 2005	F. Hoffmann-La Roche Ltd	C	Corporate
	May. 2005	Forward Ventures	C	Venture Capital
	May. 2005	GeneChem Management Inc.	C	Venture Capital
	May. 2005	Gimv NV	C	Private Equity
	May. 2005	GrowthWorks Capital Ltd.	C	Venture Capital
Details		Total Round C $50,000,000
	Nov. 2007	View	D	Private Equity
	Nov. 2007	View	D	Venture Capital
	Nov. 2007	View	D	Private Equity
	Nov. 2007	View	D	Venture Capital
	Nov. 2007	View	D	Private Equity
	Nov. 2007	View	D	Venture Capital
	Nov. 2007	View	D	Private Equity
	Nov. 2007	View	D	Venture Capital
	Nov. 2007	View	D	Venture Capital
	Nov. 2007	View	D	Venture Capital
	Nov. 2007	View	D	Private Equity
	Nov. 2007	View	D	Venture Capital
Details		Total Round D View
	Oct. 2010	View	Debt Funding	Venture Capital
Details		Total Round Debt Funding View
	May. 2011	View	D	Private Equity
	May. 2011	View	D	Private Equity
	May. 2011	View	D	Venture Capital
	May. 2011	View	D	Venture Capital
	May. 2011	View	D	Venture Capital
	May. 2011	View	D	Venture Capital
	May. 2011	View	D	Venture Capital
	May. 2011	View	D	Private Equity
	May. 2011	View	D	Venture Capital
	May. 2011	View	D	Private Equity
	May. 2011	View	D	Venture Capital
Details		Total Round D View
	May. 2012	View	Warrant	Venture Capital
Details		Total Round Warrant View
	Nov. 2012	View	E	Private Equity
	Nov. 2012	View	E	Private Equity
	Nov. 2012	View	E	Private Equity
	Nov. 2012	View	E	Private Equity
	Nov. 2012	View	E	Venture Capital
	Nov. 2012	View	E	Venture Capital
	Nov. 2012	View	E	Venture Capital
	Nov. 2012	View	E	Venture Capital
	Nov. 2012	View	E	Venture Capital
Details		Total Round E View
		Total of Funding Shown Above View

	Date	Deal Type	Action	Resulting Status	Valuation	Amount Raised	Public Ticker
Details	Jun. 2011	View	View	View¹	View	View	View
Details	May. 2013	View	View	View²	View	View	View

1	Ambit withdrew its...Read More →
2	Ambit Biosciences Corporation raised $65,000,000...Read More →
	Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

Choose Region(s):
Or Enter Location (US, CAN, UK): within miles
Annual Revenues search is available on PrivCo Premium. Upgrade to PrivCo Premium Subscription Annual Revenues:
Industry:
Go to Advanced Search

Ambit Biosciences Corporation

Business Summary

Overview & Corporate Organization

Basic Information

Industry Information

Industry Codes

PrivCo Industries (Sector > Industry > Sub-Industry)

Ownership

Charts, Financials, and Statistics (Table Format)

Charts, Financials, and Statistics (Graphs)

Ambit Biosciences Corporation Other Sales Revenue, Net - Services ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Revenue from Contract ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Other Operating Revenue ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Revenue ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Cost of Services - Other ($ MM): (Displayed as graph)

Ambit Biosciences Corporation General and Administrative Expenses ($ MM): (Displayed as graph)

Ambit Biosciences Corporation In - Process Research and Development ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Research and Development Expense (Excluding In - Process) ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Total Operating Expenses excluding costs ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Operating Income/(Loss) ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Interest Expense ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Gain/(Loss) on Sale of Business ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Other Nonoperating-Asset Related Income ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Nonoperating Income - Other ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Nonoperating Income/(Expense) - Other ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Nonoperating Income/(Expense) ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Income/(Loss) from Continuing Operations Before Income Taxes ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Provision for Income Taxes ($): (Displayed as graph)

Ambit Biosciences Corporation Minority Interest, Net of Tax Effect ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Net Income ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Other Preferred Stock Dividends and Adjustments ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Net Income Applicable to Common Stockholders ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Comprehensive Foreign Currency Exchange Gains/(Losses) ($): (Displayed as graph)

Ambit Biosciences Corporation Total Comprehensive Net Income ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Cash and Cash Equivalents ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Short-Term Investments ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Restricted Cash ($): (Displayed as graph)

Ambit Biosciences Corporation Net Accounts Receivable Trade ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Prepaid Expenses ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Assets Held-for-Sale ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Assets ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Net Property, Plant and Equipment ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Noncurrent Other Assets ($): (Displayed as graph)

Ambit Biosciences Corporation Assets ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Employee Related Liabilities ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Other Accounts Payable and Accrued Expenses ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Deferred/(Unearned) Revenue ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Notes Payable ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Liabilities Held for Sale ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Other Liabilities ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Liabilities ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Notes Payable - Long-Term ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Minority Interest ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Deferred/(Unearned) Revenue - Long-Term ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Noncurrent Other Liabilities ($): (Displayed as graph)

Ambit Biosciences Corporation Convertible Preferred Stock Obligations ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Redeemable Preferred Stock Obligations ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Redeemable Convertible Preferred Stock Obligations ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Common Stock - Value (Excluding Additional Paid in Capital) ($): (Displayed as graph)

Ambit Biosciences Corporation Additional Paid in Capital ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Retained Earnings ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Other Accumulated Comprehensive Income, Net of Tax Effect ($): (Displayed as graph)

Ambit Biosciences Corporation Equity - Other ($): (Displayed as graph)

Ambit Biosciences Corporation Stockholders' Equity ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Liabilities and Stockholders' Equity ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Operating Activities Beginning Net Income ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Amortization ($): (Displayed as graph)

Ambit Biosciences Corporation Depreciation and Amortization ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Adjustment In-Process Research and Development ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Total Adjustments to Provision for Doubtful Accounts ($): (Displayed as graph)

Ambit Biosciences Corporation Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment ($): (Displayed as graph)

Ambit Biosciences Corporation Adjustments to Gain/(Loss) on Sale of Business ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Adjustment Deferred Revenue ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Adjustment for Equity Based Compensation Expense ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Adjustment Derivatives ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Adjustments to Other Deferred Charges ($): (Displayed as graph)

Ambit Biosciences Corporation Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease) ($): (Displayed as graph)

Ambit Biosciences Corporation Noncash Expenses - Other ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Change Accounts Receivable ($ MM): (Displayed as graph)

Ambit Biosciences Corporation Current Increase/(Decrease) in Notes Receivable - Related Parties ($): (Displayed as graph)

Ambit Biosciences Corporation Other Sales Revenue, Net - Services ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Revenue from Contract ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Other Operating Revenue ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Revenue ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Cost of Services - Other ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation General and Administrative Expenses ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation In - Process Research and Development ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Research and Development Expense (Excluding In - Process) ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Total Operating Expenses excluding costs ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Operating Income/(Loss) ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Interest Expense ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Gain/(Loss) on Sale of Business ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Other Nonoperating-Asset Related Income ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Nonoperating Income - Other ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Nonoperating Income/(Expense) - Other ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Nonoperating Income/(Expense) ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Income/(Loss) from Continuing Operations Before Income Taxes ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Provision for Income Taxes ($):
(Displayed as graph)

Ambit Biosciences Corporation Minority Interest, Net of Tax Effect ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Net Income ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Other Preferred Stock Dividends and Adjustments ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Net Income Applicable to Common Stockholders ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Comprehensive Foreign Currency Exchange Gains/(Losses) ($):
(Displayed as graph)

Ambit Biosciences Corporation Total Comprehensive Net Income ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Cash and Cash Equivalents ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Short-Term Investments ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Restricted Cash ($):
(Displayed as graph)

Ambit Biosciences Corporation Net Accounts Receivable Trade ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Prepaid Expenses ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Assets Held-for-Sale ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Assets ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Net Property, Plant and Equipment ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Noncurrent Other Assets ($):
(Displayed as graph)

Ambit Biosciences Corporation Assets ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Employee Related Liabilities ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Other Accounts Payable and Accrued Expenses ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Deferred/(Unearned) Revenue ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Notes Payable ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Liabilities Held for Sale ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Other Liabilities ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Liabilities ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Notes Payable - Long-Term ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Minority Interest ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Deferred/(Unearned) Revenue - Long-Term ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Noncurrent Other Liabilities ($):
(Displayed as graph)

Ambit Biosciences Corporation Convertible Preferred Stock Obligations ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Redeemable Preferred Stock Obligations ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Redeemable Convertible Preferred Stock Obligations ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Common Stock - Value (Excluding Additional Paid in Capital) ($):
(Displayed as graph)

Ambit Biosciences Corporation Additional Paid in Capital ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Retained Earnings ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Other Accumulated Comprehensive Income, Net of Tax Effect ($):
(Displayed as graph)

Ambit Biosciences Corporation Equity - Other ($):
(Displayed as graph)

Ambit Biosciences Corporation Stockholders' Equity ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Liabilities and Stockholders' Equity ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Operating Activities Beginning Net Income ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Amortization ($):
(Displayed as graph)

Ambit Biosciences Corporation Depreciation and Amortization ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Adjustment In-Process Research and Development ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Total Adjustments to Provision for Doubtful Accounts ($):
(Displayed as graph)

Ambit Biosciences Corporation Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment ($):
(Displayed as graph)

Ambit Biosciences Corporation Adjustments to Gain/(Loss) on Sale of Business ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Adjustment Deferred Revenue ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Adjustment for Equity Based Compensation Expense ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Adjustment Derivatives ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Adjustments to Other Deferred Charges ($):
(Displayed as graph)

Ambit Biosciences Corporation Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease) ($):
(Displayed as graph)

Ambit Biosciences Corporation Noncash Expenses - Other ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Change Accounts Receivable ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Current Increase/(Decrease) in Notes Receivable - Related Parties ($):
(Displayed as graph)

Ambit Biosciences Corporation Change Assets Held for Sale ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Change Deposit Other Assets ($):
(Displayed as graph)

Ambit Biosciences Corporation Change Prepaid Expenses Other Current Assets ($):
(Displayed as graph)

Ambit Biosciences Corporation Increase/(Decrease) in Accounts Payable and Accrued Expenses ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Increase/(Decrease) in Employee Related Liabilities ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Net Cash Flows Provided By/(Used In) Operating Activities ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Purchase of Property, Plant and Equipment ($ MM):
(Displayed as graph)

Ambit Biosciences Corporation Increase Decrease Restricted Funds ($):
(Displayed as graph)

Ambit Biosciences Corporation Proceeds from Divestiture of Business ($):
(Displayed as graph)

Ambit Biosciences Corporation Net Proceeds from Sale of Short-Term Investments ($ MM):
(Displayed as graph)